Oryzon Genomics Announces Bond-to-Share Conversion
Company Announcements

Oryzon Genomics Announces Bond-to-Share Conversion

Oryzon Genomics SA (ES:ORY) has released an update.

Oryzon Genomics S.A. has announced that investor Nice & Green SA has converted bonds worth 540,000 euros into 311,688 new shares at a price of 1.7325 euros per share. These new shares, with a nominal value of 0.05 euros each, will be admitted for trading across major Spanish Stock Exchanges including Madrid, Barcelona, Bilbao, and Valencia. This conversion is part of a larger convertible bond program valued at up to 45 million euros over 48 months.

For further insights into ES:ORY stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Spain Auto-Generated NewsdeskOryzon Genomics Advances Clinical Trials Amid Financial Adjustments
Catie PowersORN Upcoming Earnings Report: What to Expect?
TipRanks Spain Auto-Generated NewsdeskOryzon Genomics Advances Vafidemstat into Phase III
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App